A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared
with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.